These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3429169)

  • 21. Serum and corpuscular nickel and zinc in chronic hemodialysis patients.
    Hosokawa S; Nishitani H; Umemura K; Tomoyoshi T; Sawanishi K; Yoshida O
    Nephron; 1987; 45(2):151-3. PubMed ID: 3561623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of functional iron deficiency status in haemodialysis patients in central South Africa.
    Haupt L; Weyers R
    Int J Lab Hematol; 2016 Aug; 38(4):352-9. PubMed ID: 27136325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M; Salopek S; Möller M; Schliesser J; Klooker P; Reddig J; Gansert U; Brass H
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.
    Taylor JE; Peat N; Porter C; Morgan AG
    Nephrol Dial Transplant; 1996 Jun; 11(6):1079-83. PubMed ID: 8671972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of body iron stores on the serum erythropoietin concentration in hemodialyzed patients.
    Teruel JL; Marcen R; Navarro JF; Villafruela JJ; Fernandez Lucas M; Rivera M; Ortuño J
    Am J Nephrol; 1994; 14(2):95-8. PubMed ID: 8080013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The assessment of iron stores in children on regular dialysis treatment.
    Müller-Wiefel DE; Waldherr R; Feist D; van Kaick G
    Contrib Nephrol; 1984; 38():141-52. PubMed ID: 6713891
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum ferritin concentration: a reliable guide to iron overload in uremic and hemodialyzed patients.
    Aljama P; Ward MK; Pierides AM; Eastham EJ; Ellis HA; Feest TG; Conceicao S; Kerr DN
    Clin Nephrol; 1978 Sep; 10(3):101-4. PubMed ID: 699405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction of haemodialysis-associated anaemia by deferoxamine. Effects on serum aluminum and iron overload.
    von Bonsdorff M; Sipilä R; Pitkänen E
    Scand J Urol Nephrol Suppl; 1990; 131():49-54. PubMed ID: 2075470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The value of parameters of iron metabolism in the differential diagnosis of anemias].
    Baudach A; Tille D; Schleusner A; Müller K; Gerisch A; Lobers W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):669-75. PubMed ID: 1709900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum folate and folic acid binding proteins in iron deficiency anaemia.
    Areekul S; Ratanabanangkoon K; Hathirat P; Cheeramakara C; Srisukawat K
    Southeast Asian J Trop Med Public Health; 1979 Dec; 10(4):528-33. PubMed ID: 538503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of anaemia with desferrioxamine in haemodialysis patients.
    Praga M; Andrés A; de la Serna J; Ruilope LM; Nieto J; Estenoz J; Millet VG; Arnaiz F; Rodicio JL
    Nephrol Dial Transplant; 1987; 2(4):243-7. PubMed ID: 3118265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is anaemia during continuous ambulatory peritoneal dialysis really better than during haemodialysis?
    Salahudeen AK; Keavey PM; Hawkins T; Wilkinson R
    Lancet; 1983 Nov; 2(8358):1046-9. PubMed ID: 6138598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron supplementation in haemodialysis--practical clinical guidelines.
    Silva J; Andrade S; Ventura H; Santos JP; Colaço S; Oliveira C; Ponce P
    Nephrol Dial Transplant; 1998 Oct; 13(10):2572-7. PubMed ID: 9794562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of intravenous iron on the haematocrit of patients on maintenance haemodialysis.
    Morgan T
    Med J Aust; 1972 Apr; 1(17):852-4. PubMed ID: 5026058
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aluminium-induced, reversible microcytic anemia in chronic renal failure: clinical and experimental studies.
    Touam M; Martinez F; Lacour B; Bourdon R; Zingraff J; Di Giulio S; Drüeke T
    Clin Nephrol; 1983 Jun; 19(6):295-8. PubMed ID: 6872366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aluminium-induced anaemia in haemodialysis patients.
    McGonigle RJ; Parsons V
    Nephron; 1985; 39(1):1-9. PubMed ID: 3969184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin corrects reticuloendothelial blockade and iron status in haemodialysed patients.
    Labonia W; Rubio D; Arias C
    Nephrology (Carlton); 2005 Dec; 10(6):583-7. PubMed ID: 16354241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients.
    Tarng DC; Huang TP
    Nephrol Dial Transplant; 2002 Jun; 17(6):1063-9. PubMed ID: 12032198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Normal hemoglobin levels in children with cyanotic heart disease. Is it iron deficiency anemia?].
    Hågå P
    Tidsskr Nor Laegeforen; 1993 May; 113(14):1710-1. PubMed ID: 8322297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.